AzTrials
AzTrials

Cesarean SectionERAC-QoRNCT07790471

Enhanced Recovery Protocol Compliance and Quality of Recovery After Cesarean Delivery

An observational study of Cesarean Section and Postoperative Recovery, run by Bursa City Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective observational study will evaluate whether adherence to enhanced recovery after cesarean delivery protocols is associated with postoperative recovery quality in women undergoing elective cesarean delivery under spinal anesthesia. A total of 150 participants will be enrolled. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Assessment of Enhanced Recovery Protocol Compliance
How many people
150 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Aug 2026to 15 Oct 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult pregnant women aged 18 years or older undergoing elective cesarean delivery under spinal anesthesia at Bursa City Hospital, Türkiye. Eligible participants will have American Society of Anesthesiologists physical status II or III and will be enrolled consecutively during the study period.

Who may be able to join

  • Age 18 years or older
  • Scheduled for elective cesarean delivery
  • Planned spinal anesthesia
  • American Society of Anesthesiologists physical status II or III
  • Ability to read and understand Turkish
  • Provision of written informed consent

Who cannot join

  • Emergency cesarean delivery
  • General anesthesia or conversion from spinal to general anesthesia
  • Major obstetric hemorrhage
  • Requirement for postoperative intensive care
  • Chronic opioid use
  • Chronic pain syndrome
Show all 11Show fewer
  • Severe psychiatric disease
  • Severe neurological disease
  • Inability to communicate
  • Cognitive impairment preventing completion of study questionnaires
  • Refusal to participate

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

emre ulusoy, MD contact

05379492799

emreulusoy36@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Bursa City Hospital

    Bursa, Nilüfer, 16110

    emre ulusoy, MD, 05379492799, emreulusoy36@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Enhanced Recovery After Cesarean Delivery Protocol Compliance on Postoperative Quality of Recovery in Patients Undergoing Cesarean Delivery Under Spinal Anesthesia: A Prospective Observational Study

This prospective observational study will evaluate whether adherence to enhanced recovery after cesarean delivery protocols is associated with postoperative recovery quality in women undergoing elective cesarean delivery under spinal anesthesia. A total of 150 participants will be enrolled. Recovery quality will be assessed using the Turkish version of the Obstetric Quality of Recovery-10 questionnaire at 24 hours after surgery. Pain, opioid use, nausea, mobilization, oral intake, breastfeeding, and patient satisfaction will also be evaluated.

Being tested
Assessment of Enhanced Recovery Protocol Compliance
Keywords
Enhanced Recovery After Cesarean Delivery, ERAC, Obstetric Quality of Recovery, ObsQoR-10, Spinal Anesthesia, Maternal Recovery, Preoperative Anxiety
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of Enhanced Recovery Protocol ComplianceOther

    Adherence to routinely implemented enhanced recovery after cesarean delivery components will be assessed during the preoperative, intraoperative, and postoperative periods. Each completed component will receive one point, and overall adherence will be calculated as a percentage. No additional interventions will be administered.

Study groups in NCT07790471
Study groupRoleWhat they receive
High ERAC ComplianceWomen undergoing elective cesarean delivery under spinal anesthesia with adherence to 80% or more of enhanced recovery protocol components.
Receives: Other: Assessment of Enhanced Recovery Protocol Compliance
Moderate ERAC ComplianceWomen undergoing elective cesarean delivery under spinal anesthesia with adherence to 60% to 79% of enhanced recovery protocol components.
Receives: Other: Assessment of Enhanced Recovery Protocol Compliance
Low ERAC ComplianceWomen undergoing elective cesarean delivery under spinal anesthesia with adherence to less than 60% of enhanced recovery protocol components.
Receives: Other: Assessment of Enhanced Recovery Protocol Compliance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Obstetric Quality of Recovery-10 Score

    Postoperative recovery quality will be assessed using the Turkish version of the Obstetric Quality of Recovery-10 questionnaire. Total scores range from 0 to 100, with higher scores indicating better recovery.

    Measured: 24 hours after cesarean delivery

Secondary outcomes (7)
  1. Enhanced Recovery Protocol Compliance

    Overall compliance with enhanced recovery protocol components will be calculated as the percentage of completed preoperative, intraoperative, and postoperative components.

    Measured: From the preoperative assessment to 24 hours after cesarean delivery

  2. Postoperative Pain Intensity

    Pain intensity will be assessed using the Numeric Rating Scale, ranging from 0 to 10, with higher scores indicating greater pain intensity.

    Measured: In the recovery unit and at 2, 6, 12, and 24 hours after cesarean delivery

  3. Rescue Opioid Requirement

    The number of participants requiring rescue opioid medication after cesarean delivery will be recorded.

    Measured: During the first 24 hours after cesarean delivery

  4. Total Amsterdam Preoperative Anxiety and Information Scale Score

    The overall Amsterdam Preoperative Anxiety and Information Scale score will be calculated. Scores range from 6 to 30, with higher scores indicating greater anxiety and information needs.

    Measured: Before cesarean delivery

  5. Length of Hospital Stay

    Duration of hospital stay from the completion of cesarean delivery until formal hospital discharge, measured in hours.

    Measured: From cesarean delivery until hospital discharge, assessed up to 7 days

  6. Preoperative Information Requirement

    Preoperative information needs will be evaluated using the information subscale of the Amsterdam Preoperative Anxiety and Information Scale. Scores range from 2 to 10, with higher scores indicating greater information needs.

    Measured: Before cesarean delivery

  7. Preoperative Anxiety

    Preoperative anxiety will be evaluated using the anxiety subscale of the Amsterdam Preoperative Anxiety and Information Scale. Scores range from 4 to 20, with higher scores indicating greater anxiety.

    Measured: Before cesarean delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2026
  2. Study start15 Aug 2026
  3. Primary completion15 Oct 2026 (estimated)
  4. Study completion15 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07790471
Sponsor's protocol ID
BSHE6
Acronym
ERAC-QoR
Status last verified
Aug 2026
First submitted
23 Aug 2026
Last updated
27 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because of participant confidentiality and institutional data protection policies. Only aggregated study results will be published.

Questions about this trial

What is this clinical trial studying?

An observational study of Cesarean Section and Postoperative Recovery, run by Bursa City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact emre ulusoy, MD (05379492799, emreulusoy36@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Obstetric Quality of Recovery-10 Score (time frame: 24 hours after cesarean delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in